Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Lung Cancer

Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations

Taiho Oncology Inc. and Cullinan Therapeutics Inc. (NASDAQ:CGEM) shared new data on Sunday from the central nervous system (CNS) involvement cohort of the REZILIENT2 study of zipalertinib for advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations (ex20ins) or uncommon non-ex20ins EGFR mutations.

Benzinga

bioAffinity Stock Up Over 50%: What's Driving the Surge?

Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products. The Texas-based company builds non-invasive diagnostics for lung cancer.

Benzinga

GB3 race winner Macintyre steps back from racing after cancer diagnosis

The former Ginetta Junior and British Formula 4 runner-up has begun treatment for brain and lung cancer but is determined to get back on track

Autosport

From analysis to the latest developments in health,
read the most diverse news in one place.

‘I kept asking: “Why? What did I do?”’ How come so many young, fit, non-smoking women are getting lung cancer?

For decades, lung cancer has been viewed as a disease of older men who smoked. Now, cases among young women are on the rise and doctors are baffled. Could air pollution be behind it?

The Guardian - UK

Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,…

Benzinga

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co (NYSE:BMY) shared interim Phase 2 data on pumitamig (BNT327/BMS986545) plus chemotherapy in patients with untreated extensive-stage small cell lung cancer (ES-SCLC).

Benzinga

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer (WCLC).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

FDA Breakthrough Status Awarded To Lilly-Merck Combo Drug For Advanced Non-Small Cell Lung Cancer

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s (NYSE:LLY) olomorasib, in combination with Merck Co. Inc.’s (NYSE:MRK) anti-PD-1 therapy Keytruda (pembrolizumab), for the first-line treatment of unresectable advanced or metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation…

Benzinga

NHS trust warned of ‘neglect’ after failure to spot patient’s fatal lung cancer

Anne Lorraine Dyson died on February 24 after being monitored for lung disease since September 2021.

The Independent UK

Cigarette filters do nothing for smokers’ health and just create plastic pollution – they should be banned

Cigarette filters were widely introduced in the 1950s, ostensibly to make smoking less harmful. With growing public concern about lung cancer and other smoking-related diseases, the tobacco industry responded not by making cigarettes safer, but by making them seem safer. Filters were the perfect innovation – not for health, but…

The Conversation

Trans Minnesota Shooter Says Lung Cancer Was Motive For School Shooting: 'I Want To Go Out on my Own Means'

Minnesota school shooter Robin Westman, 23, left a suicide note blaming vaping-induced lung cancer as the motive for fatally shooting two children and injuring 17 others during a Catholic Mass; the FBI labels the attack a hate-motivated terrorist act.

International Business Times UK

Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analyst

Summit Therapeutics Inc (NASDAQ:SMMT) and Akeso said ivonescimab, a PD-1xVEGF bispecific antibody, can extend patients' lives for EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) progressed after EGFR-TKI treatment.

Benzinga

Tristan Rogers Cancer Battle Exposed: The Truth Behind the 'General Hospital' Star's Final Days

Tristan Rogers, beloved General Hospital star, died at 79 following a brief fight with lung cancer. Discover details of his diagnosis, career legacy and final days.

International Business Times UK

Tristan Rogers death: Longtime ‘General Hospital’ star dies at 79 after cancer battle

Actor Tristan Rogers had been battling lung cancer and his manager said he was never a smoker

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Bored Panda

“Turns Out I Wasn’t Just Fat & Lazy”: 47 Times Doctors Got It Wrong — And Patients Paid The Price

Has your doctor ever dismissed your concerns and medically gaslit you?

The Independent UK

Doctor warns of hand symptom that can reveal advanced lung cancer

On World Lung Cancer Day, Dr. Davood Johari is warning people about the often-overlooked signs of lung cancer

Benzinga

Why Is Silexion Therapeutics Stock Trading Higher On Thursday?

Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data on Thursday, revealing inhibition rates of up to 97% in pancreatic cancer cells and almost 90% in colorectal cancer cells.

The Independent UK

Eating ultra-processed foods could increase risk of lung cancer

IN FULL

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Lung cancer warning for foods which make up ‘half the average diet’ after new study

A study linked ultra-processed foods to 32 harmful health effects including a higher risk of heart disease, cancer, type 2 diabetes, adverse mental health and early death

Evening Standard

Study suggests link between ultra processed foods and lung cancer

Researchers looked at UPF consumption and cases of lung cancer among more than 100,000 adults.

Benzinga

AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial of Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy.

Benzinga

Facing Stage 4 Cancer At 52, She's Still Working — But Needs Answers On Social Security For Her Family

At just 52 years old, a woman has been diagnosed with Stage 4 lung cancer. A non-smoker who had worked full-time since age 22, she now faces a terminal illness while trying to support her husband and three children — including one still in middle school. Although she's still working,…

The Conversation

Australia’s new lung cancer screening program has chosen simplicity over equity, and we’re concerned

Australia’s lung cancer screening program launched on July 1, and marks real progress and opportunity.

The Independent UK

Air pollution and herbal medicines could be behind lung cancer in non-smokers, study finds

Researchers say never-smokers living in more polluted cities have significantly more mutations linked to malignancy

The Conversation

Lung cancer screening hopes to save lives. But we also need to watch for possible harms

There is much to commend about Australia’s lung cancer screening program, which started on July 1.

1 2 3 4 5

People

Rosamund AdooKissiDebrah

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.